Kidney Transplant Recipients Susceptible to COVID-19 Variants Despite Vaccination
Vaccinated kidney transplant recipients show impaired neutralization against emerging COVID-19 variants of concern.
Vaccinated kidney transplant recipients show impaired neutralization against emerging COVID-19 variants of concern.
Investigators assessed the efficacy of fecal microbiota transplantation vs medical therapy for the treatment of Clostridioides difficile infection.
Livtencity is indicated for posttransplant CMV that does not respond to available antiviral treatments
Outcomes for elderly patients receiving liver transplants also improving.
This review discusses the importance of an early diagnosis of C diff infection in patients who have undergone HSCT and the recommended treatment options.
Researchers conducted a study to determine whether disinfecting hospital rooms with ultraviolet-C light decreases the incidence of vancomycin-resistant enterococci and Clostridioides difficile infections in immunocompromised adults.
Disproportionate increase in waiting-list registrations, liver transplants for alcoholic hepatitis associated with increasing alcohol sales.
Researchers conducted a study to assess the presentation, management, and outcomes of patients who developed nocardiosis following hematopoietic cell transplantation.
Further research is warranted to understand the potential ways fecal microbiota transplantations may improve patients’ responses to immunotherapy.
Investigators conducted a study to determine the optimal management of drug-resistant cytomegalovirus in 2 patients who previously underwent stem cell and kidney transplantation.